Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes.

IF 2.6 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Hasan Atmaca, Ertan Yetkin
{"title":"Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes.","authors":"Hasan Atmaca, Ertan Yetkin","doi":"10.1097/FJC.0000000000001686","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Despite the wide-spread use of beta-blockers, unpredictable response and overall low efficacy are the major pitfalls of beta-blocker use for premature ventricular complexes (PVCs). Accordingly, we aimed to reveal Holter-guided electrocardiographic criteria to predict the beta-blocker responder ones of PVCs. A total of 89 patients who had pre- and post-treatment Holter electrocardiogram recordings and fulfilled the inclusion criteria were retrospectively included in the study. Holter recordings were screened for heart rate variability, number of PVCs, heart rate, pre- and postcoupling intervals (CIs) in 3 different time intervals (24:00-08:00 am , 08:00 am -16:00 pm and 16:00 pm -24:00). Forty-three patients were defined as beta-blocker responder group with respect to 70% decrease in PVCs burden. Heart rate variability analysis revealed that there were not statistically significant differences between beta-blocker responder and nonresponder groups. CI ratio [(post-PVC CI + pre-PVC CI)/pre-PVC CI] of responder and nonresponder groups in 24.00 to 8.00 am time interval was statistically different (3.19 vs. 2.91, P = 0.006, respectively). Logistic regression analysis revealed that CI ratios of the PVCs during the 24:00-08:00 am intervals have significantly associated with the beta-blocker responsiveness for PVCs (odds ratio, 9.54; 95% confidence interval, 1.89-48.7; P value: 0.006). Nighttime increased CI ratio, that is, shorter CI time has been found to be an independent predictor of beta-blocker response against PVCs. Therefore, beta-blockers may be preferably recommended for PVCs, especially in those with shorter CI or increased CI ratio.</p>","PeriodicalId":15212,"journal":{"name":"Journal of Cardiovascular Pharmacology","volume":" ","pages":"364-368"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/FJC.0000000000001686","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Despite the wide-spread use of beta-blockers, unpredictable response and overall low efficacy are the major pitfalls of beta-blocker use for premature ventricular complexes (PVCs). Accordingly, we aimed to reveal Holter-guided electrocardiographic criteria to predict the beta-blocker responder ones of PVCs. A total of 89 patients who had pre- and post-treatment Holter electrocardiogram recordings and fulfilled the inclusion criteria were retrospectively included in the study. Holter recordings were screened for heart rate variability, number of PVCs, heart rate, pre- and postcoupling intervals (CIs) in 3 different time intervals (24:00-08:00 am , 08:00 am -16:00 pm and 16:00 pm -24:00). Forty-three patients were defined as beta-blocker responder group with respect to 70% decrease in PVCs burden. Heart rate variability analysis revealed that there were not statistically significant differences between beta-blocker responder and nonresponder groups. CI ratio [(post-PVC CI + pre-PVC CI)/pre-PVC CI] of responder and nonresponder groups in 24.00 to 8.00 am time interval was statistically different (3.19 vs. 2.91, P = 0.006, respectively). Logistic regression analysis revealed that CI ratios of the PVCs during the 24:00-08:00 am intervals have significantly associated with the beta-blocker responsiveness for PVCs (odds ratio, 9.54; 95% confidence interval, 1.89-48.7; P value: 0.006). Nighttime increased CI ratio, that is, shorter CI time has been found to be an independent predictor of beta-blocker response against PVCs. Therefore, beta-blockers may be preferably recommended for PVCs, especially in those with shorter CI or increased CI ratio.

偶联间隔比预测β受体阻滞剂对早衰心室复合体的反应。
尽管β受体阻滞剂广泛使用,但不可预测的反应和整体低疗效是β受体阻滞剂用于早衰心室复合体(PVC)的主要缺陷。因此,我们旨在揭示霍尔特引导的心电图标准,以预测室性早搏的-受体阻滞剂反应。共有89例患者在治疗前和治疗后进行动态心电图记录,并符合纳入标准,回顾性纳入研究。在三个不同的时间间隔(24:00 ~ 08:00am、08:00am ~ 16:00pm和16:00pm ~ 24:00 pm)筛选动态心电图记录心率变异性(HRV)、PVC数量、心率、前后耦合时间间隔(CI)。43例患者被定义为β受体阻滞剂反应组,其室性早搏负担降低70%。HRV分析显示,受体阻滞剂应答组和非应答组之间无统计学差异。24.00 ~ 8.00 am时,反应组和非反应组的CI比((pvc后CI+ pvc前CI)/ pvc前CI)差异有统计学意义(3.19 vs. 2.91, p=0.006)。Logistic回归分析显示,上午24:00-08:00室性早搏的CI比与β受体阻滞剂对室性早搏的反应显著相关(优势比:9.54 95% CI: 1.89 -48.7, P值:0.006)夜间CI比增加即CI时间缩短是β受体阻滞剂对室性早搏反应的独立预测因子。因此,β受体阻滞剂可能更适合于室性早搏,特别是那些CI较短或CI比值增高的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.10
自引率
3.30%
发文量
367
审稿时长
1 months
期刊介绍: Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias. Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信